- TransCanna Holdings (TCAN) wholly owned subsidiary Lyfted Farms has produced its highest THC content strain to-date
- The ‘Unicorn’ strain showed a 37 per cent THC content, and the company’s previous highest-ranking strain was 32 per cent THC
- This places Unicorn among the highest THC strains on the California market, with anything above 30 per cent considered extremely high
- Process improvements included the nursing, vegetative, and transition management phases of cultivation, all conducted at TransCanna’s Daly Facility in Modesto, California
- TransCanna Holdings Inc. (TCAN) is down 1.69 per cent and is trading at $0.58 per share as of 1:56 p.m. EST
TransCanna Holdings Inc. (TCAN) wholly-owned subsidiary Lyfted Farms has produced its highest THC content strain to date.
The ‘Unicorn’ strain showed a 37 per cent THC content, and the company’s previous highest-ranking strain was 32 per cent THC.
This places Unicorn among the highest THC strains on the California market, with anything above 30 per cent considered extremely high.
Shaun Serpa, CMO for Lyfted Farms commented on these “groundbreaking” results.
“The market is hungry for strains with higher and higher THC content, and retailers make purchasing decisions primarily based on THC levels.”
The current market trend is for cannabis flower rankings above 25 per cent THC.
Most Lyfted Farms strains currently test in the 25 per cent to 30 per cent range.
‘Unicorn’ was cultivated from clones in Lyfted Farms’ existing genetics library.
Management attributes the high THC ranking to process improvements during the nursing, vegetative, and transition management phases of cultivation, all conducted at TransCanna’s Daly Facility in Modesto, California.
Lyfted Farms claims itself as one of the most extensive genetic libraries in the state of California.
“We have over 50 strains and can specialize in strains for concentrates, terpene strains, indica dominant strains, and sativa dominant strains,” said Serpa.
Most competitors have five strains at a given time due to resource limitations of space and capital.
With TransCanna’s 12,000 square foot Jerusalem facility and new 196,000 square foot Daly facility, the company can house up to ten times as many strains as the competition.
“I call our strains our ‘tools’, said Mr. Serpa, “We have the right tool for every job and can pivot quickly to provide for changing consumer demands.”
TransCanna Holdings Inc. (TCAN) is down 1.69 per cent and is trading at $0.58 per share as of 1:56 p.m. EST.